{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Hozai", "Kampo (traditional Japanese herbal medicine)", "adaptogen", "cachexia", "interleukin", "mechanistic target of rapamycin", "melatonin", "phytotherapy"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "32733236", "DateRevised": {"Year": "2024", "Month": "07", "Day": "31"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "07", "Day": "08"}], "Language": ["eng"], "ELocationID": ["917", "10.3389/fphar.2020.00917"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "11", "PubDate": {"Year": "2020"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Phytotherapy for Cachexia: Where Do We Stand?", "Pagination": {"StartPage": "917", "MedlinePgn": "917"}, "Abstract": {"AbstractText": ["In contrast to Western medicine which currently offers no approved pharmacotherapy options for cachexia, in Japan multi-component extracts of medicinal plants are used with coverage by the national health insurance. This so called \"Kampo\" medicine is an example of the modern concept of multi-component/multi-target therapy. For the three traditional preparations Hochuekkito (), Juzentaihoto (), and Rikkunshito (), a multitude of clinical research data relating to cachexia has been published. These preparations are also referred to as \"Hozai\" (). A similar concept is found in Russian herbal medicine, where the term \"Adaptogen\" was coined for pharmacologically active substances which enhance adaptive stress repose.", "Scientific literature-including original Japanese articles-was reviewed regarding the effects of these herbal preparations on cachexia. Cachexia is a complex set of symptoms including muscle atrophy with loss of weight, fatigue, and weakness.", "In a 1985 study by Kuroda et al., Hochuekkito showed efficacy in involuntary weight loss and fatigue in 63% of 162 patients with genitourinary cancer. For cancer-related fatigue, a significant improvement was reported within 2 weeks by Jeong et al. in 2010. In patients with chronic fatigue syndrome, Hochuekkito showed an overall improvement with 8-12 weeks of therapy in a 1997 study by Kuratsune et al. In a 2005 randomized placebo-controlled trial by Satoh et al. on 13 geriatric Q1 patients in a 16-week treatment protocol, Hochuekkito showed significant improvement of general health, physical functioning and the Profile of Mood States (POMS). In 71 geriatric COPD patients in a 2009 placebo-controlled randomized study, Tatsumi et al. found a significant body weight increase and a CRP, TNF-\u03b1, IL-6 decrease over 6 months of therapy. For Juzentaihoto in 48 hepatocellular carcinoma patients, Tsuchiya et al. 2008 documented a significantly longer recurrence-free survival (49 vs. 24 months) as compared to the control group (p=0.023). For the much simpler Rikkunshito prescription, a 2011 retrospective study by Fujitsuka et al. on 39 Stage III/IV pancreatic cancer patients treated with Gemcitabine (n=33) or Gemcitabine/Rikkunshito (n=6) showed a significantly prolonged median survival with 224 vs. 378.5 days (p < 0.05). In a 2011 open-label clinical study by Utumi et al. on geriatric cachexia in 6 dementia patients, treatment with Rikkunshito for 4 weeks resulted in a significant body weight increase. In all the above studies, the standardized dosage of 3x2.5 g/d extract granules for most Japanese health insurance-covered Kampo extract-preparations was applied.", "As there is currently no accepted pharmacotherapy option for cachexia available in the West, a transfer of these East Asian gold standard prescriptions into the European market would be desirable. We were further able to demonstrate that the mTOR, interleucin, and melatonin pathways are modified by herbal compounds which thus counteract cachexia. More research in this field is urgently needed in order to provide new, effective treatments for cachexia patients."], "CopyrightInformation": "Copyright \u00a9 2020 Kuchta and Cameron."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinic for Gastroenterology and Gastrointestinal Oncology, University of G\u00f6ttingen Medical School, G\u00f6ttingen, Germany."}], "LastName": "Kuchta", "ForeName": "Kenny", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinic for Gastroenterology and Gastrointestinal Oncology, University of G\u00f6ttingen Medical School, G\u00f6ttingen, Germany."}], "LastName": "Cameron", "ForeName": "Silke", "Initials": "S"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "\n\u201cCachexia\u201d \nMerriam-Webster.com Dictionary, Merriam-Webster, https://www.merriam-webster.com/dictionary/cachexia Accessed 8 Feb. 2020."}, {"Citation": "Afreen F., Zobayed S. M., Kozai T. (2006). Melatonin in Glycyrrhiza uralensis: response of plant roots to spectral quality of light and UV-B radiation. J. Pineal Res. 41 (2), 108\u2013115. 10.1111/j.1600-079X.2006.00337.x", "ArticleIdList": ["10.1111/j.1600-079X.2006.00337.x", "16879315"]}, {"Citation": "Amitani M., Amitani H., Sloan R. A., Suzuki H., Sameshima N., Asakawa A., et al. (2015). The translational aspect of complementary and alternative medicine for cancer with particular emphasis on Kampo. Front. Pharmacol. 6, 150. \u00a010.3389/fphar.2015.00150", "ArticleIdList": ["10.3389/fphar.2015.00150", "PMC4527580", "26300773"]}, {"Citation": "Azhar G., Wei J. Y. (2006). Nutrition and cardiac cachexia. Curr. Opin. Nutr. Metab. Care 9, 18\u201323. 10.1097/01.mco.0000198060.10991.50", "ArticleIdList": ["10.1097/01.mco.0000198060.10991.50", "16340656"]}, {"Citation": "Chen X., Wu Y., Yang T., Wei M., Wang Y., Deng X., et al. (2016). Salidroside alleviates cachexia symptoms in mouse models of cancer cachexia via activating mTOR signalling. J. Cachexia Sarcopenia Muscle 7 (2), 225\u2013232. 10.1002/jcsm.12054", "ArticleIdList": ["10.1002/jcsm.12054", "PMC4864170", "27493875"]}, {"Citation": "Choi Y. K., Jung K. Y., Woo S. M., Yun Y. J., Jun C. Y., Park J. H., et al. (2014). Effect of Sipjeondaebo-tang on cancer-induced anorexia and cachexia in CT-26 tumor-bearing mice. Mediators Inflamm. 2014, 736563. 10.1155/2014/736563", "ArticleIdList": ["10.1155/2014/736563", "PMC4052064", "24963216"]}, {"Citation": "Deng X. C., Li Y. W., Wang R. J. (2008). Effect of total saponins from Panax notoginseng on expession of melatonin receptor mRNA in gastric mucosa of stress rats. Zhong Yao Cai 31 (8), 1182\u20131184.", "ArticleIdList": ["19112897"]}, {"Citation": "Dong J., Liang W., Wang T., Sui J., Wang J., Deng Z., et al. (2019). Saponins regulate intestinal inflammation in colon cancer and IBD. Pharmacol. Res. 144, 66\u201372. 10.1016/j.phrs.2019.04.010", "ArticleIdList": ["10.1016/j.phrs.2019.04.010", "30959159"]}, {"Citation": "Fujitsuka N., Asakawa A., Uezono Y., Minami K., Yamaguchi T., Niijima A., et al. (2011). Potentiation of ghrelin signaling attenuates cancer anorexia-cachexia and prolongs survival. Trans. Psychiatry 1, e23. 10.1038/tp.2011.25", "ArticleIdList": ["10.1038/tp.2011.25", "PMC3309517", "22832525"]}, {"Citation": "Fujitsuka N., Asakawa A., Morinaga A., Amitani M. S., Amitani H., Katsuura G., et al. (2016). Increased ghrelin signaling prolongs survival in mouse models of human aging through activation of sirtuin1. Mol. Psychiatry 21 (11), 1613\u20131623. 10.1038/mp.2015.220", "ArticleIdList": ["10.1038/mp.2015.220", "PMC5078860", "26830139"]}, {"Citation": "Inui A. (1999). Cancer anorexia-cachexia syndrome: are neuropeptides the key? Cancer Res. 59, 4493\u20134501.", "ArticleIdList": ["10493494"]}, {"Citation": "Jafari-Vayghan H., Saleh-Ghadimi S., Maleki V., Moludi J., Alizadeh M. (2019). The effects of melatonin on neurohormonal regulation in cardiac cachexia: A mechanistic review. J. Cell Biochem. 120 (10), 16340\u201316351. 10.1002/jcb.29151", "ArticleIdList": ["10.1002/jcb.29151", "31168891"]}, {"Citation": "\nJuzentaihoto  (2017). http://mpdb.nibiohn.go.jp/kconsort/jp/JP17E046.pdf\n"}, {"Citation": "\nHochuekkito  (2017). http://mpdb.nibiohn.go.jp/kconsort/jp/JP17E035.pdf\n"}, {"Citation": "\nRikkunshito  (2017). http://mpdb.nibiohn.go.jp/kconsort/jp/JP17E094.pdf\n"}, {"Citation": "Jeong J. S., Ryu B. H., Kim J. S., Park J. W., Choi W. C., Yoon S. W. (2010). Bojungikki-tang for cancer-related fatigue: a pilot randomized clinical trial. Integr. Cancer Ther. 9 (4), 331\u2013338. 10.1177/1534735410383170", "ArticleIdList": ["10.1177/1534735410383170", "21059621"]}, {"Citation": "Kamei T., Kumano H., Iwata K., Nariai Y., Matsumoto T. (2000). The effect of a traditional Chinese prescription for a case of lung carcinoma. J. Altern. Complement Med. 6 (6), 557\u2013559. 10.1089/acm.2000.6.557", "ArticleIdList": ["10.1089/acm.2000.6.557", "11152062"]}, {"Citation": "Kim D. H., Moon Y. S., Lee T. H., Jung J. S., Suh H. W., Song D. K. (2003). The inhibitory effect of ginseng saponins on the stress-induced plasma interleukin-6 level in mice. Neurosci. Lett. 353 (1), 13\u201316. 10.1016/j.neulet.2003.08.070", "ArticleIdList": ["10.1016/j.neulet.2003.08.070", "14642426"]}, {"Citation": "Kuratsune H., Kuratsune H., Yamaguchi K., Tokumine Y., Machii T., Kanakura Y., et al. (1997). Effect of Kampo Medicine, \u201cHochu-ekki-to,\u201d on chronic fatigue syndrome. Clin. Res. 74, 1837\u20131845."}, {"Citation": "Kuroda M., Kotake T., Sonoda T., Maekawa M., Okajima E., Okawa T., et al. (1985). The clinical evaluation of hochuekkito for symptoms of malignant neoplasm patients. Hinyokika Kiyo 31 (1), 173\u2013177.", "ArticleIdList": ["2581427"]}, {"Citation": "Lazarev N. V., Ljublina E. I., Ljublina M. A. (1959). State of nonspecific resistance. Patol. Fiziol ExperimTer. 3, 16\u201321.", "ArticleIdList": ["14414794"]}, {"Citation": "Lazarev N. V. (1958). General and specific in action of pharmacological agents. Farmacol. Toxicol. 21, 81\u201386.", "ArticleIdList": ["0"]}, {"Citation": "Lee Y., Jung J. C., Jang S., Kim J., Ali Z., Khan I. A., et al. (2013). Anti-Inflammatory and Neuroprotective Effects of Constituents Isolated from Rhodiola rosea. Evid. Based. Complement Alternat. Med. 514049, 1\u20139. 10.1155/2013/514049", "ArticleIdList": ["10.1155/2013/514049", "PMC3652169", "23690847"]}, {"Citation": "Liu H., Zhao J., Fu R., Zhu C., Fan D. (2019). The ginsenoside Rk3 exerts anti-esophageal cancer activity in vitro and in vivo by mediating apoptosis and autophagy through regulation of the PI3K/Akt/mTOR pathway. PloS One 14 (5), e0216759. 10.1371/journal.pone.0216759", "ArticleIdList": ["10.1371/journal.pone.0216759", "PMC6519821", "31091245"]}, {"Citation": "Ma C., Hu L., Tao G., Lv W., Wang H. (2015). An UPLC-MS-based metabolomics investigation on the anti-fatigue effect of salidroside in mice. J. Pharm. BioMed. Anal. 105, 84\u201390. 10.1016/j.jpba.2014.11.036", "ArticleIdList": ["10.1016/j.jpba.2014.11.036", "25543286"]}, {"Citation": "Miyano K., Ohshima K., Suzuki N., Furuya S., Yoshida Y., Nonaka M., et al. (2020). Japanese Herbal Medicine Ninjinyoeito Mediates Its Orexigenic Properties Partially by Activating Orexin 1 Receptors. Front. Nutr. 7, 5. \u00a010.3389/fnut.2020.00005", "ArticleIdList": ["10.3389/fnut.2020.00005", "PMC7056666", "32175325"]}, {"Citation": "Narsale A. A., Carson J. A. (2014). Role of interleukin-6 in cachexia: therapeutic implications. Curr. Opin. Supp. Palliat Care 8, 321\u2013327. 10.1097/SPC.0000000000000091", "ArticleIdList": ["10.1097/SPC.0000000000000091", "PMC4323347", "25319274"]}, {"Citation": "Okumi H., Koyama A. (2014). Kampo medicine for palliative care in Japan. Biopsychosoc. Med. 8 (1), 6. 10.1186/1751-0759-8-6", "ArticleIdList": ["10.1186/1751-0759-8-6", "PMC3901338", "24447861"]}, {"Citation": "Panossian A., Seo E. J., Efferth T. (2018). Novel molecular mechanisms for the adaptogenic effects of herbal extracts on isolated brain cells using systems biology. Phytomedicine 50, 257\u2013284. 10.1016/j.phymed.2018.09.204", "ArticleIdList": ["10.1016/j.phymed.2018.09.204", "30466987"]}, {"Citation": "Puppa M. J., White J. P., Velazquez K. T., Baltgalvis K. A., Sato S., Baynes J. W., et al. (2012). The effect of exercise on il-6-induced cachexia in the apc (min/+) mouse. J. Cachexia Sarcopenia Muscle 3, 117\u2013137. 10.1007/s13539-011-0047-1", "ArticleIdList": ["10.1007/s13539-011-0047-1", "PMC3374019", "22476915"]}, {"Citation": "Puppa M. J., Gao S., Narsale A. A., Carson J. A. (2014). Skeletal muscle glycoprotein 130\u2019s role in lewis lung carcinoma-induced cachexia. FASEB J. 28, 998\u20131009. 10.1096/fj.13-240580", "ArticleIdList": ["10.1096/fj.13-240580", "PMC3898653", "24145720"]}, {"Citation": "Satoh N., Sakai S., Kogure T., Tahara E., Origasa H., Shimada Y., et al. (2005). A randomized double blind placebo-controlled clinical trial of Hochuekkito, a traditional herbal medicine, in the treatment of elderly patients with weakness N of one and responder restricted design. Phytomedicine 12, 549\u2013554. 10.1016/j.phymed.2004.06.014", "ArticleIdList": ["10.1016/j.phymed.2004.06.014", "16121514"]}, {"Citation": "Shin H. Y., Shin C. H., Shin T. Y., Lee E. J., Kim H. M. (2003). Effect of bojungikki-tang on lipopolysaccharide-induced cytokine production from peripheral blood mononuclear cells of chronic fatigue syndrome patients. Immunopharmacol. Immunotoxicol. 25, 491\u2013501. 10.1081/IPH-120026435", "ArticleIdList": ["10.1081/IPH-120026435", "14686792"]}, {"Citation": "\nSuppl II JP X. V. I. (2014). http://kconsort.umin.jp/JP/JP16s2E035.pdf."}, {"Citation": "Tatsumi K., Shinozuka N., Nakayama K., Sekiya N., Kuriyama T., Fukuchi Y., et al. (2009). Hochuekkito improves systemic inflammation and nutritional status in elderly patients with chronic obstructive pulmonary disease. J. Am. Geriatr. Soc. 57, 169\u2013170. 10.1111/j.1532-5415.2009.02034.x", "ArticleIdList": ["10.1111/j.1532-5415.2009.02034.x", "19170793"]}, {"Citation": "Terawaki K., Sawada Y., Kashiwase Y., Hashimoto H., Yoshimura M., Suzuki M., et al. (2014). New cancer cachexia rat model generated by implantation of a peritoneal disseminationderived human stomach cancer cell line. Am. J. Physiol. Endocrinol. Metab. 306 (4), E373\u2013E387. 10.1152/ajpendo.00116.2013", "ArticleIdList": ["10.1152/ajpendo.00116.2013", "24347053"]}, {"Citation": "Terawaki K., Kashiwase Y., Sawada Y., Hashimoto H., Yoshimura M., Ohbuchi K., et al. (2017). Development of ghrelin resistance in a cancer cachexia rat model using human gastric cancer-derived 85As2 cells and the palliative effects of the kampo medicine rikkunshito on the model. PloS One 12 (3), e0173113. 10.1371/journal.pone.0173113", "ArticleIdList": ["10.1371/journal.pone.0173113", "PMC5332064", "28249026"]}, {"Citation": "Terawaki K., Kashiwase Y., Uzu M., Nonaka M., Sawada Y., Miyano K., et al. (2018). Leukemia inhibitory factor via the Toll-like receptor 5 signaling pathway involves aggravation of cachexia induced by human gastric cancer-derived 85As2 cells in rats. Oncotarget 9 (78), 34748\u201334764. 10.18632/oncotarget.26190", "ArticleIdList": ["10.18632/oncotarget.26190", "PMC6205166", "30410674"]}, {"Citation": "Tomono H., Ito Y., Watanabe T. (2006). Successful antiemetic treatment of Tsumura rikkunshi-to extract granules for ethical use in addition to other antiemetic agents in neoadjuvant chemotherapy for an advanced breast cancer patient. Jpn. J. Cancer Chemother. 33, 1129\u20131131.", "ArticleIdList": ["16912533"]}, {"Citation": "Tsuchiya M., Kono H., Matsuda M., Fujii H., Rusyn I. (2008). Protective effect of Juzen-taiho-to on hepatocarcinogenesis is mediated through the inhibition of Kupffer cell-induced oxidative stress. Int. J. Cancer 123, 2503\u20132511. 10.1002/ijc.23828", "ArticleIdList": ["10.1002/ijc.23828", "PMC2571981", "18785209"]}, {"Citation": "Utumi Y., Iseki E., Murayama N., Nozawa M., Kumagai R., Matsubara Y., et al. (2011). Effect of Rikkunshi-to on appetite loss found in elderly dementia patients: a preliminary study. Psychogeriatrics 11, 34\u201339. 10.1111/j.1479-8301.2010.00347.x", "ArticleIdList": ["10.1111/j.1479-8301.2010.00347.x", "21447107"]}, {"Citation": "von Haehling S., Anker S. D. (2005). Future prospects of anticytokine therapy in chronic heart failure. Expert Opin. Invest. Drugs 14, 163\u2013176. 10.1517/13543784.14.2.163", "ArticleIdList": ["10.1517/13543784.14.2.163", "15806710"]}, {"Citation": "von Haehling S., Lainscak M., Springer J., Anker S. D. (2009). Cardiac cachexia: a systematic overview. Pharmacol. Ther. 121 (3), 227\u2013252. 10.1016/j.pharmthera.2008.09.009", "ArticleIdList": ["10.1016/j.pharmthera.2008.09.009", "19061914"]}, {"Citation": "von Haehling S., Arends J., Blum D., Hacker U. (2017). Kachexie bei Tumorerkrankungen: Erkennen und multimodal behandeln Vol. 1 (Auflage: Springer Verlag; )."}, {"Citation": "Wagner H. (2006). Multitarget therapy - the future of treatment for more than just functional dyspepsia. Phytomedicine 13 Suppl 5, 122\u2013129. 10.1016/j.phymed.2006.03.021", "ArticleIdList": ["10.1016/j.phymed.2006.03.021", "16772111"]}, {"Citation": "White J. P., Baynes J. W., Welle S. L., Kostek M. C., Matesic L. E., Sato S., et al. (2011). The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the apc(min/+) mouse. PloS One 6, e24650. 10.1371/journal.pone.0024650", "ArticleIdList": ["10.1371/journal.pone.0024650", "PMC3176277", "21949739"]}, {"Citation": "White J. P., Puppa M. J., Gao S., Sato S., Welle S. L., Carson J. A. (2013). Muscle mtorc1 suppression by il-6 during cancer cachexia: A role for ampk. Am. J. Physiol. Endocrinol. Metab. 304, E1042\u2013E1052. 10.1152/ajpendo.00410.2012", "ArticleIdList": ["10.1152/ajpendo.00410.2012", "PMC3651620", "23531613"]}, {"Citation": "Yae S., Takahashi F., Yae T., Yamaguchi T., Tsukada R., Koike K., et al. (2012). Hochuekkito (TJ-41), a Kampo Formula, Ameliorates Cachexia Induced by Colon 26 Adenocarcinoma in Mice. Evid. Based. Complement Alternat. Med. 2012, 976926. 10.1155/2012/976926", "ArticleIdList": ["10.1155/2012/976926", "PMC3543823", "23326296"]}, {"Citation": "Yasui H. (2005). Acupuncture and Integrative Medicine. J. Kampo 1 (special), 85\u2013101."}, {"Citation": "Yoon M. S. (2017). Mtor as a key regulator in maintaining skeletal muscle mass. Front. Physiol. 8, 788. 10.3389/fphys.2017.00788", "ArticleIdList": ["10.3389/fphys.2017.00788", "PMC5650960", "29089899"]}, {"Citation": "Yu S.-C., Li X.-Y. (2000). Effect of ginsenoside on IL-1\u03b2 and IL-6 mRNA expression in hippocampal neurons of chronic inflammation model of aged rats. Acta Pharmacolog. Sin. 21 (10), 915\u2013918.", "ArticleIdList": ["11501043"]}, {"Citation": "Zhao H., Zhang X., Chen X., Li Y., Ke Z., Tang T., et al. (2014). Isoliquiritigenin, a flavonoid from licorice, blocks M2 macrophage polarization in colitis-associated tumorigenesis through downregulating PGE2 and IL-6. Toxicol. Appl. Pharmacol. 279 (3), 311\u2013321. 10.1016/j.taap.2014.07.001", "ArticleIdList": ["10.1016/j.taap.2014.07.001", "25026504"]}, {"Citation": "Zhong H., Wu H., Bai H., Wang M., Wen J., Gong J., et al. (2019). Panax notoginseng saponins promote liver regeneration through activation of the PI3K/AKT/mTOR cell proliferation pathway and upregulation of the AKT/Bad cell survival pathway in mice. BMC Complement Altern. Med. 19 (1), 122. 10.1186/s12906-019-2536-2", "ArticleIdList": ["10.1186/s12906-019-2536-2", "PMC6558887", "31182089"]}]}], "History": [{"Year": "2020", "Month": "2", "Day": "29"}, {"Year": "2020", "Month": "6", "Day": "5"}, {"Year": "2020", "Month": "8", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "8", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "8", "Day": "1", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "7", "Day": "8"}], "PublicationStatus": "epublish", "ArticleIdList": ["32733236", "PMC7360856", "10.3389/fphar.2020.00917"]}}]}